Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Non-Current Debt (2025)

Historic Non-Current Debt for Genmab A (GNMSF) over the last 1 years, with Q4 2025 value amounting to $5.0 billion.

  • Genmab A's Non-Current Debt changed N/A to $5.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 billion, marking a year-over-year change of. This contributed to the annual value of $5.0 billion for FY2025, which is N/A changed from last year.
  • Latest data reveals that Genmab A reported Non-Current Debt of $5.0 billion as of Q4 2025.
  • Over the past 5 years, Genmab A's Non-Current Debt peaked at $5.0 billion during Q4 2025, and registered a low of $5.0 billion during Q4 2025.